Van Dongen H, Leary EB, Drake C, Bogan R, Jaeger J, Rosenberg R, Streicher C, Kwak H, Bates J, Tabuteau H. Effects of Solriamfetol on Cognition in Participants with Cognitive Impairment Associated with Excessive Daytime Sleepiness in Obstructive Sleep Apnea: SHARP Study Results. Sleep Medicine Sleep Medicine Suppl 1, Abstracts from the 17th World Sleep Congress, Oct 2023.

Gozal D, Van Dongen H, Leary EB, Gursahani H, Parks G, Floam S, Tabuteau H. Solriamfetol Improves Cognitive Performance in Preclinical Models of Sleep Apnea and in a Randomized Placebo-Controlled Study of Sleep Apnea Participants (SHARP). Sleep Medicine Suppl 1, Abstracts from the 17th World Sleep Congress, Oct 2023.

Nichols D, Macfadden W, Leary EB, Gwadry-Sridhar F, Owens J. CATNAP: Burden of Pediatric Narcolepsy on Patients and Caregivers. Sleep Medicine Suppl 1, Abstracts from the 17th World Sleep Congress, Oct 2023.

Suh S, Lok R, Weed L, Cho A, Mignot E, Leary E, Zeitzer J. Fatigued but not sleepy? An empirical investigation of the differentiation between fatigue and sleepiness in sleep disorder patients. Sleep Medicine Suppl 1, Abstracts from the 17th World Sleep Congress, Oct 2023.

Leary EB, Pfister C, Fuller DS, Macfadden W. Effectiveness and Optimization of Lower-Sodium Oxybate in Participants With Narcolepsy Switching From Sodium Oxybate (SEGUE). Sleep 46(suppl_1) A2259-A260, May 2023, DOI: 10.1093/sleep/zsad077.0591.

Van Dongen H, Leary EB, Drake C, Bogan R, Jaeger J, Rosenberg R, Streicher C, Kwak H, Bates J, Tabuteau H. Solriamfetol Demonstrates Durable Cognitive Improvement in Adults with Obstructive Sleep Apnea and Excessive Daytime Sleepiness. Sleep 46(suppl_1) A246, May 2023, DOI: 10.1093/sleep/zsad077.0559.

Husain A, Zee P, Leary EB, Macfadden W, Fuller DS, Candler S, Bae C. Patient-Reported Sleep Quality in People With Narcolepsy Transitioning From Sodium Oxybate to Low-Sodium Oxybate. Sleep 46(suppl_1) A262, May 2023, DOI: 10.1093/sleep/zsad077.0598.

Bae C, Zee P, Leary EB, Macfadden W, Fuller DS, Candler S, Husain A. Treatment Satisfaction and Preferences in People With Narcolepsy Transitioning From Sodium Oxybate to Lower-Sodium Oxybate. Sleep 46(suppl_1) A268, May 2023, DOI: 10.1093/sleep/zsad077.0611.

Nichols D, Macfadden W, Leary EB, Gwadry-Sridhar F, Owens J. Hybrid Decentralized Recruitment Approach to a Rare Disease Registry for Pediatric Patients With Narcolepsy: The CATNAP® Registry. Sleep 46(suppl_1) A260-A261, May 2023, DOI: 10.1093/sleep/zsad077.0594.

Leary EB, Bujanover S, Zhang J, Jaeger J, Van Dongen H. Trial design: Solriamfetol’s effect on cognitive Health in Apnea participants during a Randomized Placebo-controlled study (SHARP). Sleep Medicine, Volume 100, Suppl 1, S285-S286 Dec 2022, DOI: 10.1016/j.sleep.2022.05.771.

Leary EB, Kirby T, Skowronski R, Xu K, Pfister C, Macfadden W. Effectiveness and Treatment Optimization Among Participants With Narcolepsy Switching From Sodium Oxybate to Lower-Sodium Oxybate: Interim Data From the SEGUE Study. Sleep 45(suppl_1) A177, June 2022, DOI: 10.1093/sleep/zsac079.392.

Leary EB, Zee P, Fuller DS, Macfadden W, Steininger T, Bae C, Husain AM. Efficacy and Safety in People With Narcolepsy Transitioning From Sodium Oxybate to Lower-Sodium Oxybate: Data From the Real-World TENOR Study. Sleep 45(suppl_1) A176-177, June 2022, DOI: 10.1093/sleep/zsac079.391.

Husain A, Leary EB, Fuller DS, Macfadden W, Whalen M, Bae C, Zee P. Dosing and Reasons for Transitioning From Sodium Oxybate to Lower-Sodium Oxybate in People With Narcolepsy: Data From the Real-World TENOR Study. Sleep 45(suppl_1) A174, June 2022, DOI: 10.1093/sleep/zsac079.385.

Van Dongen H, Dronamraju N, Macfadden W, Leary EB. Baseline characteristics: Solriamfetol’s effect on cognitive Health in Apnea participants during a Randomized Placebo-controlled study (SHARP). Sleep 45(suppl_1) A332, June 2022, DOI: 10.1093/sleep/zsac079.758.

Macfadden W, Leary EB, Gwadry-Sridhar F, Owens J. Children, Adolescents, and Their providers: the Narcolepsy Assessment Partnership (CATNAP™) Pediatric Narcolepsy Registry: Baseline Demographics. Sleep 45(suppl_1) A172-173, June 2022, DOI: 10.1093/sleep/zsac079.382.